| 14 May 2026 | TENDER | Apellis Pharmaceuticals, Inc. | 1,177,222 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 41,250 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 41,250 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 10,030 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 10,030 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 12,920 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 12,920 | — | |
| 14 May 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 25,840 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 25,840 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 4,909 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 3,372 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 11,284 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 25,840 | — | |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 108,622 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 82,500 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 110,000 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 95,000 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 50,974 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 56,250 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 45,000 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 30,845 | — | deriv |
| 14 May 2026 | OTHER | Apellis Pharmaceuticals, Inc. | 9,805 | — | deriv |
| 28 Jan 2026 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 25,840 | 0.00 USD | |
| 22 Jan 2026 | SALE | Apellis Pharmaceuticals, Inc. | 5,928 | 21.77 USD | |
| 20 Jan 2026 | SALE | Apellis Pharmaceuticals, Inc. | 909 | 19.79 USD | |